Use of bisphosphonates in advanced prostate cancer: Current status

by Wolfgang Lilleby
Published 2007-01-01

Radiotherapy and inhibition of the EGF family as treatment strategies for prostate cancer: combining theragnostics with theragates

by Wolfgang Lilleby, Flavio Solca, Kathrine Røe
Published 2011-06-01

Metastatic-directed therapy using PSMA-PET/CT at PSA relapse

by Oscar Lilleby, Eivor Hernes, Wolfgang Lilleby
Published 2019-11-01

Restart of androgen deprivation therapy after goserelin induced pituitary apoplexy in a patient with disseminated prostate cancer a case report and five-years follow-up

by Belal Aljabri, Wolfgang Lilleby, Marta D. Switlyk, Gunnar Tafjord
Published 2021-07-01

Circulating Tumor Cell Persistence Associates with Long-Term Clinical Outcome to a Therapeutic Cancer Vaccine in Prostate Cancer

by Ingrid Jenny Guldvik, Lina Ekseth, Amar U. Kishan, Andreas Stensvold, Else Marit Inderberg, Wolfgang Lilleby
Published 2021-06-01

The Quandary of DNA-Based Treatment Assessment in De Novo Metastatic Prostate Cancer in the Era of Precision Oncology

by Sigve Nakken, Wolfgang Lilleby, Marta D. Switlyk, Karen E. Knudsen, Oscar Lilleby, Sen Zhao, Fatemeh Kaveh, Per O. Ekstrøm, Alfonso Urbanucci, Eivind Hovig
Published 2021-04-01

Identification and Validation of Leucine-rich α-2-glycoprotein 1 as a Noninvasive Biomarker for Improved Precision in Prostate Cancer Risk Stratification

by Ingrid J. Guldvik, Verena Zuber, Peder R. Braadland, Helene H. Grytli, Håkon Ramberg, Wolfgang Lilleby, Bernd Thiede, Manuela Zucknick, Fahri Saatcioglu, Randi Gislefoss, Rune Kvåle, Anne George, Henrik Grönberg, Fredrik Wiklund, David E. Neal, Vincent J. Gnanapragasam, Kristin A. Taskén, Ian G. Mills
Published 2020-10-01